The AT2R agonist C21 significantly reduced M1 macrophage accumulation and promoted Treg cell expansion in ischemia-reperfusion-induced acute kidney injury.
Does AT2R agonist C21 improve macrophage and T cell phenotypes in rats with ischemia-reperfusion-induced acute kidney injury?
AT2R activation reduces M1 macrophages and promotes Tregs accumulation in IR-AKI, shifting the kidney microenvironment towards anti-inflammation.
Absolute Event Rate: 73.16% vs 539.37%
p-value: p=<0.05
Introduction Acute kidney injury (AKI) is marked by infiltration of immune cells, particularly macrophages and T cells, and their expansion as inflammatory and anti-inflammatory mediators to create a microenvironment critical for kidney injury/repair. As the angiotensin type 2 receptor (AT 2 R) is emerging as reno-protective and anti-inflammatory, this study aimed to analyze the phenotypes of macrophages and helper T cells (CD4) in response to AT 2 R activation in ischemia-reperfusion (IR)-induced AKI. Methods Sprague Dawley rats were subjected to 30 min IR without and with AT2R agonist C21 administration. Rats were euthanized at 2 h, 3 d, and 5 d post IR. Flow cytometry of kidney digested cells was performed to analyze kidney infiltrating immune cells. For in-vitro polarization, mouse CD4 T cells were cultured in presence of various stimulus and characterized by flow cytometry and western blot analysis. Results On day 3, there was a massive increase in macrophage/monocytes (CD68 + ) and M1 (CD68 + CD86 + ) cell accumulation and a modest increase in M2 (CD68 + CD163 + ) cell accumulation. The AT2R activation reduced CD68+ and M1 cells accumulation without affecting M2. Accumulation of CD4 + CD25 + cells increased on day 3, and Tregs (CD4 + CD25 + FoxP3 + ) and Tregs-IL-10 increased at 2 h and 3 d post-IR. The AT2R agonist C21 further increased these phenotypes at all-time points. Th-17 cell accumulation increased at early time points (2 h and 3 d) but returned to normal on day 5 and was not affected by C21 treatment. Ex vivo studies revealed that AT 2 R agonist promoted CD4 + cell expansion into Tregs, which was blocked by the AT 2 R antagonist PD123319, PP2A inhibitor okadaic acid, or NO synthase inhibitor L-NAME, suggesting the direct involvement of AT 2 R-PP2A-NOS pathways. Discussion Overall, AT 2 R activation reduces M1 and promotes Tregs accumulation in IR-AKI, thus shifting the kidney microenvironment towards anti-inflammation and presents a potential mechanism to limit kidney injury and promote repair.
Ali et al. (Thu,) conducted a other in Ischemia-reperfusion-induced acute kidney injury. AT2R agonist C21 vs. Saline vehicle was evaluated on M1 macrophage (CD68+CD86+) accumulation at day 3 (x 10^3 cells/gm) (p=<0.05). The AT2R agonist C21 significantly reduced M1 macrophage accumulation and promoted Treg cell expansion in ischemia-reperfusion-induced acute kidney injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: